Moving to D&E markets, organic sales were up 2% that was driven by 7% growth in Personal Care.
On the bottom-line, adjusted earnings per share were $1.72 in the quarter, compared to $1.84 in the year-ago period.
We're investing in our brands and improving our market positions.
In North American consumer tissue, organic sales increased to 11% and that reflects strong demand due to the COVID-19 work from home environment and strong momentum on Kleenex facial tissue.
We are raising our full-year outlook and are on track to achieve excellent financial results.
We expect between the lines spending will rise further sequentially in the fourth quarter.
We also improved our market shares in many countries in the quarter.
Organic sales were down mid-single digits in ASEAN.
Third quarter adjusted gross margin was 36.2%, up 40 basis points year-on-year.
On the top-line, we now expect organic sales growth of 5% compared to our prior target of 4% to 5%.
And third, we're prudently managing the business through near-term volatility, while continuing to strengthen the long-term health of Kimberly Clark.
By segment, organic sales rose 10% in Consumer Tissue and 5% in Personal Care, but declined 15% in K-C Professional.
